Offer - Urjas Oil for just ₹ 1 X
Tesunate 25 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Malaria.
Medical history of the patient along with age and gender determines the dosage of Tesunate 25 Mg Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The most common side effects of Tesunate 25 Mg Tablet are Headache, Nausea or vomiting. Some other side effects of Tesunate 25 Mg Tablet have been listed ahead. Normally, these side effects of Tesunate 25 Mg Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Tesunate 25 Mg Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Tesunate 25 Mg Tablet related warnings talks about Tesunate 25 Mg Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Drug Allergy must refrain from the use of Tesunate 25 Mg Tablet since this can cause severe adverse effects. The section on Tesunate 25 Mg Tablet contraindications lists all such conditions.
Drug interactions for Tesunate 25 Mg Tablet have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Tesunate 25 Mg Tablet is not safe while driving, and is is not addictive in nature.
Tesunate 25 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Tesunate 25 Mg Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Tesunate. It is best to stop taking Tesunate immediately and inform your doctor if you notice any discomfort.
Is the use of Tesunate 25 Mg Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Tesunate. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Tesunate 25 Mg Tablet on the Kidneys?
In the absence of any research, there are no known side effects of Tesunate on kidneys.
What is the effect of Tesunate 25 Mg Tablet on the Liver?
Tesunate may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Tesunate 25 Mg Tablet on the Heart?
Tesunate may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Tesunate 25 Mg Tablet unless your doctor advises you to do so -
Is this Tesunate 25 Mg Tablet habit forming or addictive?
Tesunate 25 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Tesunate 25 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Tesunate 25 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Tesunate 25 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Tesunate 25 Mg Tablet
Taking Tesunate 25 Mg Tablet with food does not harm your health.
Interaction between Alcohol and Tesunate 25 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Tesunate 25 Mg Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 830